• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $GBNH

    Greenbrook TMS Inc.

    Subscribe to $GBNH
    $GBNH
    Misc Health and Biotechnology Services
    Health Care

    Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

    IPO Year:

    Exchange: NASDAQ

    Website: greenbrooktms.com

    Peers

    $STIM

    Recent Analyst Ratings for Greenbrook TMS Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Greenbrook TMS Inc. Leadership Updates

    Live Leadership Updates

    See more
    • GREENBROOK APPOINTS PETER WILLETT AS CHIEF FINANCIAL OFFICER

      TORONTO, Jan. 29, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that the Company's Board of Directors has appointed Mr. Peter Willett as the Company's full-time Chief Financial Officer, effective immediately. Mr. Willett was appointed Interim Chief Financial Officer of the Company in October 2023, prior to which he has been a key player on the Greenbrook finance team over the past six years, serving as its Senior Vice President of Finance. Peter brings over 11 years of finance experience, providing a broad base of experience and specialized knowledge about the financial and accounting matters that are unique to the mental health servic

      1/29/24 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

      TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately. Ms. Elstad has also been appointed to the Company's Governance and Nominating Committee. Juliana Elstad is a CEO, entrepreneur, and advisor with over 20 years of experience bringing medical innovation to patients and delivering success in small startup to multi-billion-dollar environments. She has a proven track record of creating, growing, and leading medical technology organizations with a focus on building dynamic cultures and mentoring high-po

      1/23/24 4:31:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS ANNOUNCES RESULTS OF VOTING AT ANNUAL MEETING OF SHAREHOLDERS

      TORONTO, June 20, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the "Meeting"). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook dated May 11, 2023 (the "Circular").   The total number of common shares represented at the Meeting was 29,769,721, representing approximately 72.96% of Greenbrook's outstanding common shares entit

      6/20/23 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Announces Results of Voting at Annual Meeting of Shareholders

      Greenbrook TMS Inc. (TSX:GTMS, NASDAQ:GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the "Meeting"). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook dated May 11, 2022 (the "Circular"). The total number of common shares represented at the Meeting was 10,711,474, representing approximately 60.17% of Greenbrook's outstanding common shares entitled to be voted. Election o

      6/21/22 5:01:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Cybin Provides 2021 Year End Summary

      Cybin Inc. (NEO:CYBN) (NYSE:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psychedelics to Therapeutics™" is pleased to provide a year-end summary of its major milestones and key catalysts from 2021 that it believes have positioned the Company for a transformative 2022. "2021 was an exciting year for Cybin. We expanded our organization from 5 to more than 55 employees across 4 countries and have established an operating ecosystem of nearly 50 partners and vendors that have supported more than 90 preclinical studies and numerous patent and investigational new drug filings over the past 12 months," said Doug Drysdale, Cybin's Chief Executive Officer. "D

      12/22/21 7:30:00 AM ET
      $CYBN
      $GBNH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Misc Health and Biotechnology Services
    • Greenbrook TMS Announces Appointment of Robert Higgins to the Board

      Greenbrook TMS Inc. (TSX:GTMS, NASDAQ:GBNH) ("Greenbrook" or the "Company") is pleased to announce the appointment of Robert Higgins to the board of directors of the Company (the "Board"), effective immediately. The appointment of Mr. Higgins increases the size of the Board to nine members. Mr. Higgins is currently Managing Director, Investment Professional & General Counsel of Masters Special Situations, LLC ("MSS"), a healthcare focused growth equity firm which he co-founded in 2020. Prior to co-founding MSS, Mr. Higgins was Vice President, Business Development & General Counsel of Arosa+LivHOME, a Bain Capital Double Impact Portfolio Company, and a premier national provider of integrate

      8/3/21 8:30:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Announces Results of Voting at Annual and Special Meeting of Shareholders

      Greenbrook TMS Inc. (TSX:GTMS, NASDAQ:GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today the results of voting at its annual and special meeting of shareholders held earlier today (the "Meeting"). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual and Special Meeting of Shareholders and Management Information Circular of Greenbrook dated May 7, 2021 (the "Circular"). The total number of common shares represented by holders by proxy at the Meeting was 8,276,984, representing approximately 60.26% of Greenbrook's outstanding commo

      6/14/21 5:05:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    Greenbrook TMS Inc. Financials

    Live finance-specific insights

    See more
    • GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

      TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the overall best interests

      2/23/24 9:00:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

      TORONTO, Feb. 15, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fifth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$2,538,071 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$87 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

      2/15/24 5:21:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$1.5 MILLION IN DEBT FINANCING

      TORONTO, Feb. 6, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fourth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$1,522,843 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$85 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

      2/6/24 5:15:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$1.5 MILLION IN DEBT FINANCING

      TORONTO, Jan. 19, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-third amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$1,522,843 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$83 million outstanding under the Credit Facility (collectively, the "Loans"). The proceeds of the New Loan are expected to be used by the Com

      1/19/24 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$5.3 MILLION IN DEBT FINANCING

      TORONTO, Dec. 28, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-second amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$5,262,952 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$81 million outstanding under the Credit Facility (collectively, the "Loans"). The proceeds of the New Loan is expected to be used by the Comp

      12/28/23 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING

      TORONTO, Dec. 15, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-first amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$4,015,548.22 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$76 million outstanding under the Credit Facility (collectively, the "Loans"). The proceeds of the New Loan is expected to be used by the Co

      12/15/23 4:30:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

      TORONTO, Dec. 5, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twentieth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional $2,500,000 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately $72 million outstanding under the Credit Facility (collectively, the "Loans"). The Amendment also provides Madryn with the option to convert up to appr

      12/5/23 4:30:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Announces Settlement of Ongoing Litigation

      TORONTO, Nov. 21, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") announced today that the Company has entered into a settlement agreement with the plaintiff regarding the previously-announced breach of contract claim in connection with an approximately $2 million promissory note that was issued to a lender associated with Mr. Benjamin Klein, a seller of Check Five LLC (doing business as "Success TMS"), that the Company acquired in July 2022 (the "Klein Note Action"). Under the terms of the settlement agreement, the Company will make payments to the plaintiff in the total amount of approximately $2.2 million, structured as an initial immediate payment of

      11/21/23 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RECEIVES NASDAQ DELISTING NOTICE AND INTENDS TO APPEAL

      TORONTO, Nov. 17, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it received notification from the Nasdaq Stock Market LLC ("Nasdaq") on November 14, 2023, that Nasdaq has determined to delist the Company's common shares (the "Common Shares") due to noncompliance with the Minimum Bid Requirement and the MVLS Requirement (each as defined below). The Company received notification on May 16, 2023 that it was not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market (NASDAQ Listing Rule 5550(a)(2)), as the bid price for the Common Shares on Nasdaq closed below US$1.00 (the "Minimum Bid R

      11/17/23 4:30:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

      TORONTO, Nov. 16, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the nineteenth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional $2,548,223.35 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately $70 million outstanding under the Credit Facility (collectively, the "Loans"). The Amendment also provides Madryn with the option to convert up to

      11/16/23 9:15:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    Greenbrook TMS Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Greybrook Announces Passing of Founder Elias Vamvakas

      TORONTO, July 11, 2024 /CNW/ - It is with heavy hearts that the Executive Team at Greybrook announces the passing of our cherished founder, Elias Vamvakas, today, after a courageous battle with pancreatic cancer. Elias was 65 years old. Elias Vamvakas was a visionary leader whose entrepreneurial spirit and dedication laid the foundation for Greybrook, a distinguished Canadian private equity firm with investments in real estate and health care. Born in 1958 in Athens, Greece, Elias immigrated to Canada in 1966. His journey from an immigrant to a celebrated business leader was a

      7/11/24 1:55:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

      TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the overall best interests

      2/23/24 9:00:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook Announces $1.2 Million Registered Direct Offering

      TORONTO, Feb. 22, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company"), today announced that it has entered into securities purchase agreements with  institutional investors for the purchase and sale of 6,000,000 common shares at a purchase price of $0.20 per share pursuant to a registered direct offering, resulting in gross proceeds of approximately $1.2 million before deducting placement agent commissions and other estimated offering expenses. The closing of the offering is expected to occur on or about February 26, 2024, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds for working capital as well as

      2/22/24 8:00:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

      TORONTO, Feb. 15, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fifth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$2,538,071 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$87 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

      2/15/24 5:21:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$1.5 MILLION IN DEBT FINANCING

      TORONTO, Feb. 6, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fourth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$1,522,843 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$85 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

      2/6/24 5:15:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK APPOINTS PETER WILLETT AS CHIEF FINANCIAL OFFICER

      TORONTO, Jan. 29, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that the Company's Board of Directors has appointed Mr. Peter Willett as the Company's full-time Chief Financial Officer, effective immediately. Mr. Willett was appointed Interim Chief Financial Officer of the Company in October 2023, prior to which he has been a key player on the Greenbrook finance team over the past six years, serving as its Senior Vice President of Finance. Peter brings over 11 years of finance experience, providing a broad base of experience and specialized knowledge about the financial and accounting matters that are unique to the mental health servic

      1/29/24 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

      TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately. Ms. Elstad has also been appointed to the Company's Governance and Nominating Committee. Juliana Elstad is a CEO, entrepreneur, and advisor with over 20 years of experience bringing medical innovation to patients and delivering success in small startup to multi-billion-dollar environments. She has a proven track record of creating, growing, and leading medical technology organizations with a focus on building dynamic cultures and mentoring high-po

      1/23/24 4:31:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$1.5 MILLION IN DEBT FINANCING

      TORONTO, Jan. 19, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-third amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$1,522,843 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$83 million outstanding under the Credit Facility (collectively, the "Loans"). The proceeds of the New Loan are expected to be used by the Com

      1/19/24 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$5.3 MILLION IN DEBT FINANCING

      TORONTO, Dec. 28, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-second amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$5,262,952 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$81 million outstanding under the Credit Facility (collectively, the "Loans"). The proceeds of the New Loan is expected to be used by the Comp

      12/28/23 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING

      TORONTO, Dec. 15, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-first amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$4,015,548.22 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$76 million outstanding under the Credit Facility (collectively, the "Loans"). The proceeds of the New Loan is expected to be used by the Co

      12/15/23 4:30:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    Greenbrook TMS Inc. SEC Filings

    See more
    • Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      3/15/24 3:46:21 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      3/8/24 3:19:54 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      3/1/24 4:58:50 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      2/26/24 1:36:08 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 424B5 filed by Greenbrook TMS Inc.

      424B5 - Greenbrook TMS Inc. (0001735948) (Filer)

      2/26/24 8:54:18 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      2/23/24 9:04:53 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      2/22/24 4:00:40 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      2/15/24 5:28:16 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      2/9/24 4:35:58 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      2/2/24 4:16:38 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    Greenbrook TMS Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      2/28/24 5:22:33 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      2/28/24 3:26:24 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      10/24/23 4:15:27 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      10/2/23 5:26:49 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      9/12/23 4:16:50 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      8/30/23 4:47:46 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      8/25/23 4:15:57 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      8/17/23 4:06:52 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      8/7/23 9:29:20 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D filed by Greenbrook TMS Inc.

      SC 13D - Greenbrook TMS Inc. (0001735948) (Subject)

      4/3/23 4:16:53 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    Greenbrook TMS Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Crish Andrew

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      3/8/24 4:51:46 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 3 filed by new insider Elstad Juliana

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      2/2/24 4:31:30 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • New insider Madryn Asset Management, Lp claimed ownership of 6,363,636 shares (SEC Form 3)

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      1/11/24 9:45:02 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • New insider Campbell Colleen Rae claimed ownership of 5,000 shares (SEC Form 3)

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      1/2/24 6:32:35 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 3 filed by new insider Willett Peter Casimir

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      1/2/24 4:29:05 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 3 filed by new insider Vamvakas Elias

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      1/2/24 4:28:35 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • New insider Tworecke Frank claimed ownership of 40,000 shares (SEC Form 3)

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      1/2/24 4:26:32 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 3 filed by new insider Mann Surindra Kaur

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      1/2/24 4:24:29 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • New insider Leonard William P claimed ownership of 832,500 shares (SEC Form 3)

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      1/2/24 4:22:40 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • New insider Greybrook Health Inc. claimed ownership of 7,000,424 shares (SEC Form 3)

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      1/2/24 4:19:03 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care